KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Cash from Investing Activities (2016 - 2025)

Rigel Pharmaceuticals has reported Cash from Investing Activities over the past 16 years, most recently at -$25.4 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 132.38% year-over-year to -$25.4 million; the TTM value through Dec 2025 reached -$92.4 million, down 2336.44%, while the annual FY2025 figure was -$92.4 million, 2336.44% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$25.4 million at Rigel Pharmaceuticals, up from -$33.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $22.6 million in Q1 2022 and troughed at -$49.7 million in Q2 2021.
  • A 5-year average of -$5.0 million and a median of $545000.0 in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 424.96% in 2024 and later crashed 3471.25% in 2025.
  • Year by year, Cash from Investing Activities stood at $6.5 million in 2021, then surged by 186.65% to $18.6 million in 2022, then tumbled by 136.96% to -$6.9 million in 2023, then plummeted by 58.77% to -$10.9 million in 2024, then plummeted by 132.38% to -$25.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RIGL at -$25.4 million in Q4 2025, -$33.2 million in Q3 2025, and -$23.3 million in Q2 2025.